The DOI matches its Crossref record; 115 of the 120 references it cites were found in a registry or an index; 164 of the 191 sources its claims cite were checked for support.
Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy
Open accessAbstract
Sepsis-associated encephalopathy (SAE) is a frequent neurological complication of sepsis, driven by six interconnected pathophysiological components: (1) systemic inflammation-triggered neuroinflammatory cascades, initiated by systemic recognition of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) and propagated by pro-inflammatory mediators; (2) central nervous system (CNS) immune cell-mediated neuroinflammation, wherein microglia, regulatory T cells, and neutrophils dynamically regulate inflammatory progression; (3) blood-brain barrier (BBB) disruption, progressing from functional disturbance to structural damage via tight junction degradation and immune infiltration; (4) multimodal programmed cell death, encompassing autophagy, apoptosis, pyroptosis, and ferroptosis driven by mitochondrial dysfunction; (5) neurotransmitter network imbalance, manifesting as cholinergic deficiency and glutamate excitotoxicity; and (6) gut-brain axis dysregulation, characterized by reduced microbiota-derived metabolites such as butyrate and indolepropionic acid. These components are organized along a core pathological axis comprising four sequential stages: neuroinflammatory storm (encompassing components 1 and 2) → BBB disruption and microcirculatory disturbances (component 3) → multimodal programmed cell death (component 4) → neurotransmitter imbalance (component 5), with the gut-brain axis (component 6) functioning as a bidirectional regulatory node that intersects and modulates all four stages. Mitochondrial dysfunction serves as the central converging node linking these pathological axes. Targeted interventions against neuroinflammation, immune cell modulation, BBB restoration, inhibition of aberrant cell death, neurotransmitter homeostasis, and gut microbiota remodeling hold therapeutic promise. Elucidating the crosstalk among these pathways will accelerate the clinical translation of precision therapies for SAE.
Overview
CoChat Summary
TL;DR
This review synthesizes evidence on sepsis-associated encephalopathy (SAE) pathogenesis into six interconnected components organized along four sequential pathological axes, with mitochondrial dysfunction as the central converging node and the gut–brain axis as a bidirectional regulatory node. It classifies interventions by clinical translation stage and highlights major barriers to clinical translation.
Key findings
- SAE occurs in more than 50% of hospitalized sepsis patients; characteristic consciousness fluctuations are associated with a three- to fivefold higher risk of death, and in-hospital mortality reaches 45–60% in severe cases.
- The review proposes six components: neuroinflammatory cascades, CNS immune cell-mediated neuroinflammation, BBB disruption, multimodal programmed cell death (autophagy, apoptosis, pyroptosis, ferroptosis), neurotransmitter network imbalance, and gut–brain axis dysregulation. These are organized as neuroinflammatory storm → BBB disruption and microcirculatory disturbances → multimodal programmed cell death → neurotransmitter imbalance, with the gut–brain axis modulating all four axes and mitochondrial dysfunction as the central converging node.
- Cited clinical/preclinical data include: SAE patients show 2.3-fold and 1.8-fold increases in peripheral blood S100β and GFAP, respectively, positively correlated with MDA accumulation (r = 0.72), alongside a 40% decrease in SOD activity; SAE model mice show 62–75% decreases in SCFA-producing bacteria and 54–68% reductions in acetate and propionate; propofol combined with dexmedetomidine reduced FTH1 expression by 58% and MDA levels by 41%.
- Intervention strategies are classified by clinical translation stage—clinically available drugs, preclinical candidates, and potential molecular targets—with examples including NAC, oxytocin, fluoxetine, dexmedetomidine, α7nAChR agonists, FMT, and SCFA/propionate supplementation.
Methods
- Narrative review with a comprehensive literature search in PubMed, Web of Science, and Embase for studies published between January 2015 and March 2026, combining MeSH terms and free-text keywords; separate searches were conducted for each pathological component (neuroinflammation, BBB disruption, cell death, neurotransmitter imbalance, gut–brain axis).
- Inclusion criteria: English original research articles, reviews, or clinical studies investigating SAE pathogenesis involving neuroinflammatory cascades, BBB disruption, cell death pathways, or gut–brain axis dysregulation; interventional studies had to report clear mechanisms of action, and reviews were included if they systematically summarized relevant evidence. Exclusion criteria included case reports with fewer than 3 subjects, conference abstracts without full text, and non-peer-reviewed publications.
- Three-stage selection identified 2500 records, of which 380 underwent full-text review; ultimately 116 references were included in the primary analysis. Data were extracted and synthesized according to four core pathological components, and intervention strategies were critically classified by clinical translation stage.
Limitations
- The paper states that the proposed integrated pathological axis is established by synthesizing evidence from diverse study designs; most included studies are observational or associative rather than designed to verify causal relationships, so causal interactions among components remain to be validated.
- The paper states reproducibility concerns and model heterogeneity: LPS injection produces rapid, transient neuroinflammation whereas CLP induces polymicrobial sepsis with more sustained CNS pathology, yielding divergent cytokine profiles and microglial activation kinetics; rodent–human differences in microglial density, BBB tight junction composition, and cholinergic system organization restrict extrapolation. It also notes that SAE lacks standardized diagnostic criteria, animal models use young healthy mice and lack mechanical ventilation, sedation, and polypharmacy, and translational challenges include poor CNS penetration, timing mismatch between preclinical prophylaxis and clinical diagnosis, unvalidated biomarkers (NGAL, S100β, GFAP), and multi-target complexity.
- Evident from the text: as a narrative review, it does not report a systematic quantitative synthesis or meta-analysis, and no formal risk-of-bias assessment tool is described.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
122 Valid · 16 Not valid · 15 Not checked · 41 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“early activation exerts protective effects via Foxc1-mediated IκBα/NF-κB signaling regulation [16]”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 3. Pathogenesis and Therapeutic Strategies > 3.2. Immune Cell-Mediated Regulation of Neuroinflammation
What the sources say
- Disputedcites [16] Wang, 2022, Overexpression of Foxc1 ameliorates sepsis-associated encephalopathy by inhibiting microglial migration and neuroinflammation through the IκBα/NF-κB pathway, Mol. Med. Rep. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says Foxc1 overexpression prevented sepsis-induced neuroinflammation and microglial migration, likely through IκBα/NF-κB signaling. It does not present early microglial activation as protective; instead, it describes inflammatory microglial activation as contributing to neuronal damage. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“IRGM1 inhibits neuronal apoptosis and activates protective autophagy by regulating p38 MAPK phosphorylation [60], while sestrin 2 exerts therapeutic effects by enhancing autophagy via the ULK1 pathway [63].”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 3. Pathogenesis and Therapeutic Strategies > 3.4. MultiModal Programmed Cell Death Interaction Mechanisms
What the sources say
- Disputedcites [60] Zhou, 2020, Regulation of hippocampal neuronal apoptosis and autophagy in mice with sepsis-associated encephalopathy by immunity-related GTPase M1, CNS Neurosci. Ther. sourceExperimental — accuracy not yet measured
The Results report that SAE-induced neuronal apoptosis was lower in Irgm1-knockout mice than in wild-type mice. The Discussion concludes that increased IRGM1 activates p38 MAPK signaling, which then induces neuronal apoptosis—not that IRGM1 inhibits it. The cited passages do not specify phosphorylation as the mechanism. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Mitochondrial regulatory networks indicate that Nogo-A induces mitophagy and apoptosis via the ROS-p-SHP2 axis [64], while Omi/HtrA2 promotes apoptosis through dual mechanisms: inhibiting XIAP and inducing mitochondrial membrane potential depolarization [65].”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 3. Pathogenesis and Therapeutic Strategies > 3.4. MultiModal Programmed Cell Death Interaction Mechanisms
What the sources say
- Disputedcites [64] Liu, 2024, Nogo-A exacerbates sepsis-associated encephalopathy by modulating microglial SHP-2/NLRP3 balance and inducing ROS and M1 polarization, Biomol. Biomed. sourceExperimental — accuracy not yet measured
The Results section (‘In vivo western blot shows Nogo-A indirectly inhibits p-SHP2 expression’; page unavailable) says Nogo-A indirectly inhibits mitochondrial autophagy, rather than inducing mitophagy. The Discussion likewise says Nogo-A knockdown enhances mitochondrial autophagy. Although the paper links Nogo-A to ROS and apoptosis-related proteins, it contradicts the claim’s direction of effect on mitophagy. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Second, therapeutic timing represents a critical disconnect—preclinical studies universally administer interventions prophylactically or within hours of insult, whereas clinical SAE is typically recognized after established pathology, potentially beyond the window for mechanism-based intervention.”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 4. Integrated Discussion and Critical Appraisal > 4.1. Synthesis of the Core Pathological Axis
What the sources say
- Disputedcites [3] Zhang, 2025, Integrated multi omics and machine learning reveal mitochondrial immunometabolic networks in sepsis associated encephalopathy, Sci. Rep. sourceExperimental — accuracy not yet measured
In “Animal maintaining” (page unavailable), the paper reports administering mtDNA or PBS to rats 24 hours after modeling, including rats whose SAE model had already been established. That is contrary to the claim that preclinical interventions are universally given prophylactically or within hours of insult. The mtDNA injection was an experimental challenge, not a therapeutic treatment; the paper does not establish the broader claim about clinical recognition or therapeutic windows. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [75] Fu, 2019, NLRP3/Caspase-1 Pathway-Induced Pyroptosis Mediated Cognitive Deficits in a Mouse Model of Sepsis-Associated Encephalopathy, Inflammation sourceExperimental — accuracy not yet measured
The Drug Administrations section reports that this mouse study first gave MCC950 or Ac-YVAD-CMK 30 minutes before surgery, supporting prophylactic initiation. It also reports doses on days 1, 2, 4, and 6 afterward. One study cannot establish that preclinical studies universally use prophylactic or within-hours administration. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Furthermore, species differences in microglial density, BBB tight junction composition, and cholinergic system organization between rodents and humans likely restrict direct extrapolation of preclinical findings to human patients [15,16,18].”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 4. Integrated Discussion and Critical Appraisal > 4.2. Critical Appraisal of Evidence and Unresolved Controversies
What the sources say
- Not checked — no full text of the sourcecites [15] Ronaldson, 2020, Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity, J. Cereb. Blood Flow Metab. source
- Could not verifycites [16] Wang, 2022, Overexpression of Foxc1 ameliorates sepsis-associated encephalopathy by inhibiting microglial migration and neuroinflammation through the IκBα/NF-κB pathway, Mol. Med. Rep. sourceExperimental — accuracy not yet measured
The Materials and methods (Animals; page unavailable) describe a mouse study, and the Discussion (page unavailable) discusses microglia and BBB disruption. Neither passage compares rodents with humans or addresses microglial density, BBB tight-junction composition, cholinergic organization, or limits on extrapolation to patients. Searches for those terms and translational limitations found no supporting passage. (LLM, conf=0.75)
- Could not verifycites [18] Haruwaka, 2019, Dual microglia effects on blood brain barrier permeability induced by systemic inflammation, Nat. Commun. sourceExperimental — accuracy not yet measured
The Methods (Strains and animal care; page not provided) describe experiments in mice, and the Introduction discusses microglia and BBB tight-junction proteins. Our copy does not compare rodents with humans in microglial density, tight-junction composition, or cholinergic organization, or discuss how such differences affect clinical extrapolation (searched for those terms and human translation). (LLM, conf=0.76)
states a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
138 more claims · 100 with their cited sources checked
Create a free account to see all 194 claims and every source verdict.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 7
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 2. Materials and Methods
“Data were extracted and synthesized according to four core pathological components consistent with the review’s framework: neuroinflammatory storms, BBB remodeling, neurotransmitter network imbalances, and gut–brain axis dysregulation.”
§ Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy > 1. Introduction
“This review systematically examines and synthesizes current evidence on six core pathological components organized along four sequential axes (Figure 1):”
Citations
Cites
NLRP3 inflammasome activation and cell death
Huang, Y., Xu, W., & Zhou, R. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00740-6 · Cited by 1,527 · cited 1×
“Simultaneously, ROS produced within endothelial cells can oxida-tively damage TJ proteins and activate the NLRP3 inflammasome, leading to caspase-1 activation and IL-1 β maturation, exacerbating local disruption in an autocrine manner [48].”
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172 · cited 2×
“The BBB is a sophisticated structure composed of brain microvascular endothelial cells (BMECs) with their tight junctions (TJ), basement membrane, astrocytic end-feet, and pericytes, serving as the critical defensive line for CNS homeostasis [44].”
Dual microglia effects on blood brain barrier permeability induced by systemic inflammation
Haruwaka, K., Ikegami, A., Tachibana, Y., Ohno, N., Konishi, H., Hashimoto, A., Matsumoto, M., Kato, D., Ono, R., Kiyama, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13812-z · Cited by 923 · cited 2×
“During sepsis, these cells undergo dynamic functional transformation: early activation exerts protective effects via Foxc1-mediated I κ B α /NF-κ B signaling regulation [16]; however, sustained activation triggered by the RAGE ligand S100B exacerbates abnormal BBB permeability [17,18].”
Sepsis-associated encephalopathy
Gofton, T. E., & Young, G. B. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.183 · Cited by 821 · cited 5×
“Sepsis-associated encephalopathy (SAE) occurs in more than 50% of hospitalized sepsis patients and is associated with high mortality [1].”
InfluentialRonaldson, P. T., & Davis, T. P. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20951995 · Cited by 392 · cited 2×
“Furthermore, species differences in microglial density, BBB tight junction composition, and cholinergic system organization between rodents and humans likely restrict direct extrapolation of preclinical findings to human patients [15,16,18].”
Superoxide Anion Chemistry—Its Role at the Core of the Innate Immunity
Andrés, C. M. C., Pérez de la Lastra, J. M., Andrés Juan, C., Plou, F. J., & Pérez-Lebeña, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031841 · Cited by 342
Sepsis-associated encephalopathy: A vicious cycle of immunosuppression
Ren, C., Yao, R.-Q., Zhang, H., Feng, Y.-W., & Yao, Y.-M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1701-3 · Cited by 259 · cited 1×
“In SAE, brain-infiltrating Tregs antagonize microglial inflammatory cascades by secreting factors like IL-10 and TGF-β , and suppress astrocytic IL-6 synthesis through the amphiregulin (AREG)-EGFR signaling axis [35,36].”
TNF-alpha-induced microglia activation requires miR-342: Impact on NF-kB signaling and neurotoxicity
Brás, J. P., Bravo, J., Freitas, J., Barbosa, M. A., Santos, S. G., Summavielle, T., & Almeida, M. I. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2626-6 · Cited by 236 · cited 1×
“In addition to the mitochondrial damage induced by TNF-α , TNF-α also induces excitotoxic neuronal injury by causing abnormal glutamate secretion from glial cells and inhibiting astrocytic reuptake [20].”
Fu, Q., Wu, J., Zhou, X.-Y., Ji, M.-H., Mao, Q.-H., Li, Q., Zong, M.-M., Zhou, Z.-Q., & Yang, J.-J. (2019) · Inflammation · doi:10.1007/s10753-018-0894-4 · Cited by 232 · cited 3×
“LPS injection produces rapid, transient neuroinflammation, whereas CLP induces polymicrobial sepsis with more sustained CNS pathology [3,75].”
Guo, S.-B., Meng, Y., Lin, L., Zhou, Z.-Z., Li, H.-L., Tian, X.-P., & Huang, W.-J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02140-6 · Cited by 225 · cited 1×
“(5) Integrating AI-driven structural biology: AlphaFold-enabled protein structure prediction may accelerate rational design of BBB-penetrant agents targeting the core pathological axis [116].”
Modulation of Syndecan-1 Shedding after Hemorrhagic Shock and Resuscitation
Haywood-Watson, R. J., Holcomb, J. B., Gonzalez, E. A., Peng, Z., Pati, S., Park, P. W., Wang, W., Zaske, A. M., Menge, T., & Kozar, R. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023530 · Cited by 217 · cited 1×
“Concurrently, the endothelial glycocalyx is sheds under inflammation and abnormal shear stress, shed components (e.g., syndecan-1) act as DAMPs to amplify inflammation, directly weakening the first physical and charge barrier against macromolecule extravasation [45,46].”
Xu, X.-E., Liu, L., Wang, Y.-C., Wang, C.-T., Zheng, Q., Liu, Q.-X., Li, Z.-F., Bai, X.-J., & Liu, X.-H. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.05.038 · Cited by 211 · cited 1×
“Caspase-1-mediated GSDMD cleavage, indicating activation of the pyroptosis pathway, has been observed in peripheral blood immune cells of sepsis patients, suggesting the involvement of programmed cell death mechanisms in disease progression [37].”
Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier
Doll, D. N., Hu, H., Sun, J., Lewis, S. E., Simpkins, J. W., & Ren, X. (2015) · Stroke · doi:10.1161/strokeaha.115.009099 · Cited by 202 · cited 1×
“Uncoupling of oxidative phosphorylation reduces ATP generation, while maintaining TJ structure and supporting active transport are highly energy-consuming processes; this energy crisis directly impairs barrier function [47].”
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10
Xie, L., Choudhury, G. R., Winters, A., Yang, S., & Jin, K. (2015) · European Journal of Immunology · doi:10.1002/eji.201444823 · Cited by 185 · cited 1×
“In SAE, brain-infiltrating Tregs antagonize microglial inflammatory cascades by secreting factors like IL-10 and TGF-β , and suppress astrocytic IL-6 synthesis through the amphiregulin (AREG)-EGFR signaling axis [35,36].”
Huffman, W. J., Subramaniyan, S., Rodriguiz, R. M., Wetsel, W. C., Grill, W. M., & Terrando, N. (2019) · Brain Stimulation · doi:10.1016/j.brs.2018.10.005 · Cited by 181 · cited 2×
“Peripheral inflammation triggers central cytokine release via vagus nerve-mediated signal transduction, forming a vicious neuro-immune cycle [94].”
Li, H.-R., Liu, Q., Zhu, C.-L., Sun, X.-Y., Sun, C.-Y., Yu, C.-M., Li, P., Deng, X.-M., & Wang, J.-F. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102745 · Cited by 163 · cited 1×
“…pathway [69]; fisetin inhibits IL-1 β secretion via the mitophagy-NLRP3 axis [70]; NMN alleviates oxidative damage through the NAD+/SIRT1 pathway [71]; Lrg1 silencing reduces neuronal apoptosis by suppressing the TGF β 1/SMAD signaling pathway [72]; 3 ⃝ Non-pharmacological interventions and…”
Chung, H.-Y., Wickel, J., Hahn, N., Mein, N., Schwarzbrunn, M., Koch, P., Ceanga, M., Haselmann, H., Baade-Büttner, C., von Stackelberg, N., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq7806 · Cited by 156 · cited 1×
“HMGB1 inhibitors restore synaptic pruning balance [25,26]; MFGE8 enhances α V β integrin-mediated efferocytosis [27,28]; the microglial depletion agent PLX5622 prevents synaptic engulfment [29].”
Yin, X.-Y., Tang, X.-H., Wang, S.-X., Zhao, Y.-C., Jia, M., Yang, J.-J., Ji, M.-H., & Shen, J.-C. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02756-3 · Cited by 138 · cited 1×
“HMGB1 inhibitors restore synaptic pruning balance [25,26]; MFGE8 enhances α V β integrin-mediated efferocytosis [27,28]; the microglial depletion agent PLX5622 prevents synaptic engulfment [29].”
Chen, S., Tang, C., Ding, H., Wang, Z., Liu, X., Chai, Y., Jiang, W., Han, Y., & Zeng, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594071 · Cited by 132 · cited 1×
“(2) Epigenetic regulation: TRIM45 aggravates microglial pyroptosis by promoting K63-linked polyubiquitination ubiquitination and stabilization of Atg5, thereby disrupting autophagic flux and activating the NLRP3 inflammasome [78]; Maf1 inhibits NF-κ B/p65-driven inflammasome assembly [79].”
Shen, Y., Zhang, Y., Du, J., Jiang, B., Shan, T., Li, H., Bao, H., & Si, Y. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02300-1 · Cited by 129
Ding, H., Li, Y., Chen, S., Wen, Y., Zhang, S., Luo, E., Li, X., Zhong, W., & Zeng, H. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13765 · Cited by 126 · cited 2×
“…stem cells mitigate inflammation and apoptosis via the PI3K/AKT pathway [69]; fisetin inhibits IL-1 β secretion via the mitophagy-NLRP3 axis [70]; NMN alleviates oxidative damage through the NAD+/SIRT1 pathway [71]; Lrg1 silencing reduces neuronal apoptosis by suppressing the TGF β 1/SMAD…”
Wei, X.-B., Jiang, W.-Q., Zeng, J.-H., Huang, L.-Q., Ding, H.-G., Jing, Y.-W., Han, Y.-L., Li, Y.-C., & Chen, S.-L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02738-1 · Cited by 123 · cited 1×
“Interventions include: (1) acetaminophen (APAP) restores the GPX4 pathway to inhibit ferroptosis [89]; (2) MAR1 reshapes the SLC7A11/GPX4 signaling pathway to suppress microglial activation [90]; (3) Exosomal NEAT1 exacerbates ferroptosis via the miR-9-5p/TFRC-GOT1 axis [91].”
Zhang, H., Xu, J., Wu, Q., Fang, H., Shao, X., Ouyang, X., He, Z., Deng, Y., & Chen, C. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s350566 · Cited by 94 · cited 1×
“Molecular mechanisms involve: (1) Butyrate activates the GPR109A/Nrf2/HO-1 pathway [106]; (2) Indolepropionic acid (IPA) inhibits the NLRP3 inflammasome and IL-1 β secretion [107]; (3) NU9056 upregulaes SCFA levels to antagonize inflammasome activity [108].”
Forebrain Cholinergic Dysfunction and Systemic and Brain Inflammation in Murine Sepsis Survivors
Zaghloul, N., Addorisio, M. E., Silverman, H. A., Patel, H. L., Valdés-Ferrer, S. I., Ayasolla, K. R., Lehner, K. R., Olofsson, P. S., Nasim, M., Metz, C. N., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01673 · Cited by 89 · cited 1×
“In the septic environment, choline acetyltransferase (ChAT)-positive neurons in key brain regions such as the hippocampus are reduced in number and activity, leading to insufficient synthesis of the anti-inflammatory mediator acetylcholine (ACh) [7].”
Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice
Fang, H., Wang, Y., Deng, J., Zhang, H., Wu, Q., He, L., Xu, J., Shao, X., Ouyang, X., He, Z., et al. (2022) · mSystems · doi:10.1128/msystems.01399-21 · Cited by 87 · cited 1×
“Molecular mechanisms involve: (1) Butyrate activates the GPR109A/Nrf2/HO-1 pathway [106]; (2) Indolepropionic acid (IPA) inhibits the NLRP3 inflammasome and IL-1 β secretion [107]; (3) NU9056 upregulaes SCFA levels to antagonize inflammasome activity [108].”
Ye, B., Tao, T., Zhao, A., Wen, L., He, X., Liu, Y., Fu, Q., Mi, W., & Lou, J. (2019) · Mediators of Inflammation · doi:10.1155/2019/8461725 · Cited by 83 · cited 1×
“In-filtration of peripheral TH1/TH17 cells into the CNS leads to aberrant IL-17A secretion, which further promotes persistent microglial activation via a positive feedback loop [19].”
Treg cell therapy: How cell heterogeneity can make the difference
Giganti, G., Atif, M., Mohseni, Y., Mastronicola, D., Grageda, N., Povoleri, G. A., Miyara, M., & Scottà, C. (2021) · European Journal of Immunology · doi:10.1002/eji.201948131 · Cited by 82 · cited 1×
“…tissue microenvironmental balance by suppressing excessive immune responses and can migrate across the BBB into CNS. Activation of nicotinic acetylcholine receptors on their surface promotes clonal expansion within the hippocampus and modulates neuroinflammation via acetylcholine signaling [33,34].”
Keever, K. R., Yakubenko, V. P., & Hoover, D. B. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106758 · Cited by 82
Liu, Y., Yang, H., Luo, N., Fu, Y., Qiu, F., Pan, Z., Li, X., Jian, W., Yang, X., Xue, Q., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04345-7 · Cited by 79 · cited 1×
“…[72]; 3 ⃝ Non-pharmacological interventions and potential targets: Environmental enrichment (EE) exerts protective effects by enhancing antioxidant, anti-inflammatory, and anti-apoptotic responses [73]; FGR gene silencing regulates mitochondrial homeostasis via the Sirt1/PGC-1 α pathway [74].”
Gold nanoparticles reduce inflammation in cerebral microvessels of mice with sepsis
Di Bella, D., Ferreira, J. P. S., Silva, R. D. N. O., Echem, C., Milan, A., Akamine, E. H., Carvalho, M. H., & Rodrigues, S. F. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00796-6 · Cited by 69
Gao, L., Wang, Z., Mu, Y., Liu, Z., & Pang, L. (2021) · Pathobiology · doi:10.1159/000520281 · Cited by 67 · cited 1×
“2 ⃝ Preclinical research: Emodin simultaneously inhibits apoptosis and activates autophagy via the BDNF/TrkB signaling pathway [68]; umbilical cord mesenchymal stem cells mitigate inflammation and apoptosis via the PI3K/AKT pathway [69]; fisetin inhibits IL-1 β secretion via the mitophagy-NLRP3…”
Saito, M., Fujinami, Y., Ono, Y., Ohyama, S., Fujioka, K., Yamashita, K., Inoue, S., & Kotani, J. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.010 · Cited by 66
Liu, J., Jin, Y., Ye, Y., Tang, Y., Dai, S., Li, M., Zhao, G., Hong, G., & Lu, Z.-Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626894 · Cited by 66 · cited 1×
“Exogenous SCFA intervention can dose-dependently inhibit peripheral pro-inflammatory factor release and exert neuroprotection by upregulating tight junction proteins and blocking microglial JNK/NF-κ B activation [104,105].”
Xu, Z.-Q., Zhang, W.-J., Su, D.-F., Zhang, G.-Q., & Miao, C.-Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-273 · Cited by 60 · cited 2×
“First, BBB permeability: many promising preclinical targets tend to exhibit poor CNS penetration, requiring doses that may risk peripheral toxicity [12,13,22].”
TRIM45 aggravates microglia pyroptosis via Atg5/NLRP3 axis in septic encephalopathy
Huang, X., Ye, C., Zhao, X., Tong, Y., Lin, W., Huang, Q., Zheng, Y., Wang, J., Zhang, A., & Mo, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02959-8 · Cited by 60 · cited 1×
“(2) Epigenetic regulation: TRIM45 aggravates microglial pyroptosis by promoting K63-linked polyubiquitination ubiquitination and stabilization of Atg5, thereby disrupting autophagic flux and activating the NLRP3 inflammasome [78]; Maf1 inhibits NF-κ B/p65-driven inflammasome assembly [79].”
Liao, H., Li, H., Bao, H., Jiang, L., Du, J., Guo, Y., & Si, Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.909436 · Cited by 55 · cited 1×
“Exogenous SCFA intervention can dose-dependently inhibit peripheral pro-inflammatory factor release and exert neuroprotection by upregulating tight junction proteins and blocking microglial JNK/NF-κ B activation [104,105].”
Hassan, F. I., Didari, T., Baeeri, M., Gholami, M., Haghi‐Aminjan, H., Khalid, M., Nigjeh, M. N., Rahimifard, M., Solgi, S., Abdollahi, M. R., et al. (2020) · PubMed Central · doi:10.22074/cellj.2020.7046 · Cited by 53
Zhang, Q., Liu, X.-M., Hu, Q., Liu, Z.-R., Liu, Z.-Y., Zhang, H.-G., Huang, Y.-L., Chen, Q.-H., Wang, W.-X., & Zhang, X.-K. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03027-6 · Cited by 52 · cited 1×
“Dexmedetomidine, beyond its sedative effects via α 2 receptors, activates the neuronal mitochondrial deacetylase Sirt3, improving oxidative phosphorylation and reducing reactive oxygen species (ROS) production [10,11].”
Poles, M. Z., Nászai, A., Gulácsi, L., Czakó, B. L., Gál, K. G., Glenz, R. J., Dookhun, D., Rutai, A., Tallósy, S. P., Szabó, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717157 · Cited by 49 · cited 1×
“Kynurenic acid (KYNA) exerts neuroprotective effects by inhibiting NET formation, maintaining BBB integrity, and improving mitochondrial function [41].”
Yue, J., Tan, Y., Huan, R., Guo, J., Yang, S., Deng, M., Xiong, Y., Han, G., Liu, L., Liu, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1090288 · Cited by 46 · cited 1×
“The cascade reaction between myeloid cells and vascular endothelium induces microthrombus formation and perfusion disturbances, forming a central regulatory network of the vascular-immune-neural axis [43].”
Xi, S., Wang, Y., Wu, C., Peng, W., Zhu, Y., & Hu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.783049 · Cited by 46 · cited 1×
“…remodeling strategies show that fecal microbiota transplantation (FMT) improves neurotransmitter balance by modulating the IBA-1 axis, inhibits M1 polarization and IL-1 β cycling in mesenteric lymph node macrophages, and blocks gut epithelial exosome-mediated neuroinflammatory cascades [109].”
Zhou, S., Li, Y., Hong, Y., Zhong, Z., & Zhao, M. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175616 · Cited by 45 · cited 1×
“…via the HIF-1 α /BNIP3L axis [85]; 2 ⃝ Natural compounds (preclinical): Puerarin enhances BBB stability by blocking GSDMD cleavage; myricitrin alleviates neuroinflammation by modulating the Bax/Bcl-2 balance [86]; malvidin dually inhibits pyroptosis and apoptosis via the AMPK α /UCP2 axis [87].”
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing
Manabe, T., Rácz, I., Schwartz, S., Oberle, L., Santarelli, F., Emmrich, J. V., Neher, J. J., & Heneka, M. T. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15491 · Cited by 44 · cited 1×
“HMGB1 inhibitors restore synaptic pruning balance [25,26]; MFGE8 enhances α V β integrin-mediated efferocytosis [27,28]; the microglial depletion agent PLX5622 prevents synaptic engulfment [29].”
Zhao, P., Li, X., Yang, Q., Lu, Y., Wang, G., Yang, H., Dong, J., & Zhang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1038802 · Cited by 43 · cited 1×
“…via the HIF-1 α /BNIP3L axis [85]; 2 ⃝ Natural compounds (preclinical): Puerarin enhances BBB stability by blocking GSDMD cleavage; myricitrin alleviates neuroinflammation by modulating the Bax/Bcl-2 balance [86]; malvidin dually inhibits pyroptosis and apoptosis via the AMPK α /UCP2 axis [87].”
Li, Z., Zhang, F., Sun, M., Liu, J., Zhao, L., Liu, S., Li, S., & Wang, B. (2023) · PeerJ · doi:10.7717/peerj.15122 · Cited by 43 · cited 1×
“Metabolic interventions: Molecular hydrogen improves metabolic-inflammatory imbalance via microbiota modulation [113]; propionate supplements exert protective effects by maintaining BBB integrity [114].”
Zhu, C.-L., Xie, J., Liu, Q., Wang, Y., Li, H.-R., Yu, C.-M., Li, P., Deng, X.-M., Bian, J.-J., & Wang, J.-F. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79913 · Cited by 42 · cited 1×
“Mechanistically, phosphorylated STAT3 (p-Y705) in neutrophils forms a complex with PD-L1, driving nuclear translocation and upregulating GSDMD expression to promote NETosis [40].”
Fu, Q., Zhang, Y.-B., Shi, C.-X., Jiang, M., Lu, K., Fu, Z.-H., Ruan, J.-P., Wu, J., & Gu, X.-P. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03084-w · Cited by 42
Zhou, R., Li, Y., Qu, Y., Huang, Q., Sun, X., Mu, D., & Li, X. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13229 · Cited by 42 · cited 2×
“Dysregulated mitochondrial quality control, including VDAC1-related mechanisms and impaired PINK1/Parkin-mediated mitophagy, further links autophagy dysfunction to neuronal injury [60,61].”
Zhong, X., Xie, L., Yang, X., Liang, F., Yang, Y., Tong, J., Zhong, Y., Zhao, K., Tang, Y., & Yuan, C. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00181-3 · Cited by 42 · cited 1×
“Intervention strategies classified by clinical transformation stage: 1 ⃝ Preclinical research: Ethyl pyruvate inhibits NLRP3 [80]; TXNIP knockdown protects against sepsis-induced brain injury and cognitive decline by suppressing oxidative stress and neuroin-flammation [81]; mesenchymal stem…”
HIF-1α/BNIP3L induced cognitive deficits in a mouse model of sepsis-associated encephalopathy
Zhao, L., Song, Y., Zhang, Y., Liu, H., Shen, Y., Fan, Y., Li, Y., & Xie, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1095427 · Cited by 39 · cited 1×
“…via the Nrf2/autophagy pathway [83,84]; echinomycin improves mitochondrial structure and reduces inflammatory factors via the HIF-1 α /BNIP3L axis [85]; 2 ⃝ Natural compounds (preclinical): Puerarin enhances BBB stability by blocking GSDMD cleavage; myricitrin alleviates neuroinflammation by…”
Pan, C., Si, Y., Meng, Q., Jing, L., Chen, L., Zhang, Y., & Bao, H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00358 · Cited by 37
Ge, C., Chen, W., Zhang, L., Ai, Y., Zou, Y., & Peng, Q. (2023) · Theranostics · doi:10.7150/thno.82889 · Cited by 37 · cited 1×
“…via the N-methyl-D-aspartate receptor (NMDAR)/ α -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-cAMP response element-binding protein (CREB)-brain-derived neurotrophic factor (BDNF) axis, and specific receptor antagonists can reverse related molecular abnormalities [96,97].”
Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis
Mein, N., von Stackelberg, N., Wickel, J., Geis, C., & Chung, H.-Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02975-8 · Cited by 36 · cited 1×
“HMGB1 inhibitors restore synaptic pruning balance [25,26]; MFGE8 enhances α V β integrin-mediated efferocytosis [27,28]; the microglial depletion agent PLX5622 prevents synaptic engulfment [29].”
Wang, H., Wang, H., Song, Y., Liu, C., Qian, X., Zhang, D., Jiang, X., & Zhang, S. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12623 · Cited by 36 · cited 2×
“During sepsis, these cells undergo dynamic functional transformation: early activation exerts protective effects via Foxc1-mediated I κ B α /NF-κ B signaling regulation [16]; however, sustained activation triggered by the RAGE ligand S100B exacerbates abnormal BBB permeability [17,18].”
Ma, Y., She, X., Liu, Y., & Qin, X. (2024) · Communications Biology · doi:10.1038/s42003-024-06236-z · Cited by 36 · cited 1×
“…oxidative stress and neuroin-flammation [81]; mesenchymal stem cell-derived exosomes deliver miR-140-3p to inhibit HMGB1-mediated pyroptosis [82]; hydrogen-rich saline blocks inflammasome activation via the Nrf2/autophagy pathway [83,84]; echinomycin improves mitochondrial structure and…”
Omi/HtrA2 Protease Associated Cell Apoptosis Participates in Blood-Brain Barrier Dysfunction
Hu, Y., Bi, Y., Yao, D., Wang, P., & Li, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00048 · Cited by 36 · cited 1×
“Mitochondrial regulatory networks indicate that Nogo-A induces mitophagy and apoptosis via the ROS-p-SHP2 axis [64], while Omi/HtrA2 promotes apoptosis through dual mechanisms: inhibiting XIAP and inducing mitochondrial membrane potential depolarization [65].”
Wang, H., Xu, L., Tang, X., Jiang, Z., & Feng, X. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02116-x · Cited by 35 · cited 4×
“Third, biomarker availability: while NGAL, S100 β , and GFAP appear to show diagnostic promise [42,88], none are validated for real-time monitoring.”
InfluentialYin, L., Zhang, J., Ma, H., Zhang, X., Fan, Z., Yang, Y., Li, M., Han, J., & Zhang, X. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.01.019 · Cited by 34 · cited 1×
“LPS-induced abnormalities in septal-hippocampal cholinergic projections can be restored through circuit reprogramming to recover synaptic plasticity [98].”
Zhang, Y., Xing, C., Liu, X., Li, Y.-H., Jia, J., Feng, J., Yang, C., Chen, Y., & Zhou, J. F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8645714 · Cited by 34 · cited 1×
“…[80]; TXNIP knockdown protects against sepsis-induced brain injury and cognitive decline by suppressing oxidative stress and neuroin-flammation [81]; mesenchymal stem cell-derived exosomes deliver miR-140-3p to inhibit HMGB1-mediated pyroptosis [82]; hydrogen-rich saline blocks inflammasome…”
Luo, L., Wu, J., Qiao, L., Lu, G., Li, J., & Li, D. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15313 · Cited by 33 · cited 1×
“IRGM1 inhibits neuronal apoptosis and activates protective autophagy by regulating p38 MAPK phosphorylation [60], while sestrin 2 exerts therapeutic effects by enhancing autophagy via the ULK1 pathway [63].”
Wu, H., Li, N., Peng, S., Fu, H., Hu, Z., & Su, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111792 · Cited by 32 · cited 1×
“Interventions include: (1) acetaminophen (APAP) restores the GPX4 pathway to inhibit ferroptosis [89]; (2) MAR1 reshapes the SLC7A11/GPX4 signaling pathway to suppress microglial activation [90]; (3) Exosomal NEAT1 exacerbates ferroptosis via the miR-9-5p/TFRC-GOT1 axis [91].”
Chen, L., Qing, W., Yi, Z., Lin, G., Peng, Q., & Zhou, F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.701760 · Cited by 31 · cited 1×
“Molecular mechanisms involve: (1) Butyrate activates the GPR109A/Nrf2/HO-1 pathway [106]; (2) Indolepropionic acid (IPA) inhibits the NLRP3 inflammasome and IL-1 β secretion [107]; (3) NU9056 upregulaes SCFA levels to antagonize inflammasome activity [108].”
Zhou, Z., Yang, Y., Wei, Y., & Xie, Y. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04115-x · Cited by 30 · cited 2×
“First, BBB permeability: many promising preclinical targets tend to exhibit poor CNS penetration, requiring doses that may risk peripheral toxicity [12,13,22].”
Ge, C., Chen, W., Zhang, L., Ai, Y., Zou, Y., & Peng, Q. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14013 · Cited by 29 · cited 1×
“…via the N-methyl-D-aspartate receptor (NMDAR)/ α -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-cAMP response element-binding protein (CREB)-brain-derived neurotrophic factor (BDNF) axis, and specific receptor antagonists can reverse related molecular abnormalities [96,97].”
Sun, X., Zhou, R., Lei, Y., Hu, J., & Li, X. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147109 · Cited by 28 · cited 1×
“(1) Ion channel regulation: The P2X7 receptor activates cortical pyroptosis pathways via ERK1/2 phosphorylation [76]; pannexin-1 regulates the autophagy-pyroptosis balance through AMPK signaling [77].”
lncRNA Neat1 regulates neuronal dysfunction post-sepsis via stabilization of hemoglobin subunit beta
Wu, Y., Li, P., Liu, L., Goodwin, A. J., Halushka, P. V., Hirose, T., Nakagawa, S., Zhou, J., Liu, M., & Fan, H. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.03.011 · Cited by 28 · cited 1×
“In epigenetic regulation, the Neat1/Hbb axis impairs dendritic spine density by down-regulating postsynaptic density protein-95 (PSD-95) expression, while MFHAS1-siRNA intervention can significantly reduce A β pathological burden and repair dendritic morphology [99,100].”
Dong, H., Dai, X., Zhou, Y., Shi, C., Bhuiyan, P., Sun, Z., Li, N., & Jin, W. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03028-4 · Cited by 27 · cited 1×
“Furthermore, treatments targeting impaired meningeal lymphatic drainage (e.g., promoting VEGF-C expression) help accelerate the clearance of harmful substances from the brain, creating a favorable microenvironment for BBB repair [57].”
Zhong, H., Liu, T., Shang, Y., Huang, C., & Pan, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117042 · Cited by 27 · cited 1×
“…deliver miR-140-3p to inhibit HMGB1-mediated pyroptosis [82]; hydrogen-rich saline blocks inflammasome activation via the Nrf2/autophagy pathway [83,84]; echinomycin improves mitochondrial structure and reduces inflammatory factors via the HIF-1 α /BNIP3L axis [85]; 2 ⃝ Natural compounds…”
Dumbuya, J. S., Chen, X., Du, J., Li, S., Liang, L., Xie, H., & Zeng, Q. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110758 · Cited by 27 · cited 1×
“…deliver miR-140-3p to inhibit HMGB1-mediated pyroptosis [82]; hydrogen-rich saline blocks inflammasome activation via the Nrf2/autophagy pathway [83,84]; echinomycin improves mitochondrial structure and reduces inflammatory factors via the HIF-1 α /BNIP3L axis [85]; 2 ⃝ Natural compounds…”
Han, Q., Bai, Y., Zhou, C., Dong, B., Li, Y., Luo, N., Chen, H., & Yu, Y. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14043 · Cited by 26 · cited 1×
“Metabolic interventions: Molecular hydrogen improves metabolic-inflammatory imbalance via microbiota modulation [113]; propionate supplements exert protective effects by maintaining BBB integrity [114].”
miR-25-3p ameliorates SAE by targeting the TLR4/NLRP3 axis
Luo, X.-Y., Ying, J.-H., & Wang, Q.-S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01017-1 · Cited by 24 · cited 1×
“…stage: 1 ⃝ Preclinical research: CD137L neutralizing antibody TKS-1 inhibits M1 polarization [21]; α 7nAChR agonist remimazolam activates the Nrf2/HO-1 pathway [22]; miR-25-3p inhibits IL-1 β signaling via the TLR4/NLRP3 axis [23]; miR-494 maintains mitochondrial metabolic homeostasis [24].”
Chu, J., Jiang, Y., Zhou, W., Zhang, J., Li, H., Yu, Y., & Yu, Y. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271221133547 · Cited by 24 · cited 2×
“Interventions include: (1) acetaminophen (APAP) restores the GPX4 pathway to inhibit ferroptosis [89]; (2) MAR1 reshapes the SLC7A11/GPX4 signaling pathway to suppress microglial activation [90]; (3) Exosomal NEAT1 exacerbates ferroptosis via the miR-9-5p/TFRC-GOT1 axis [91].”
Disease Outcome and Brain Metabolomics of Cyclophilin-D Knockout Mice in Sepsis
Kobayashi, T., Uchino, H., Elmér, E., Ogihara, Y., Fujita, H., Sekine, S., Ishida, Y., Saiki, I., Shibata, S., & Kawachi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020961 · Cited by 22
Miao, Y., Wang, M., Cai, X., Zhu, Q., & Mao, L. (2022) · Bioengineered · doi:10.1080/21655979.2022.2048775 · Cited by 22 · cited 1×
“…oxidative damage through the NAD+/SIRT1 pathway [71]; Lrg1 silencing reduces neuronal apoptosis by suppressing the TGF β 1/SMAD signaling pathway [72]; 3 ⃝ Non-pharmacological interventions and potential targets: Environmental enrichment (EE) exerts protective effects by enhancing antioxidant,…”
Lei, Y., Zhou, R., Sun, X., Tang, F., Gao, H., Chen, L., & Li, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-6579 · Cited by 22 · cited 2×
“(1) Ion channel regulation: The P2X7 receptor activates cortical pyroptosis pathways via ERK1/2 phosphorylation [76]; pannexin-1 regulates the autophagy-pyroptosis balance through AMPK signaling [77].”
Tian, Y., Wang, L., Fan, X., Zhang, H., Dong, Z., & Tao, T. (2023) · PLOS ONE · doi:10.1371/journal.pone.0279964 · Cited by 21 · cited 1×
“2 ⃝ Natural Compounds: β -patchoulene, β -elemene, and resveratrol glycoside exert anti-inflammatory effects by modulating pathways such as Sirt1/Nrf2 and RAC1/MLK3/p38 [30–32].”
Zhu, C., Wang, D., Chang, C., Liu, A., Zhou, J., Yang, T., Jiang, Y., Li, X., & Jiang, W. (2024) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2024.28.3.239 · Cited by 21 · cited 1×
“Dexmedetomidine, beyond its sedative effects via α 2 receptors, activates the neuronal mitochondrial deacetylase Sirt3, improving oxidative phosphorylation and reducing reactive oxygen species (ROS) production [10,11].”
Zhou, R., Sun, X., Li, Y., Huang, Q., Qu, Y., Mu, D., & Li, X. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.020 · Cited by 21 · cited 2×
“Dysregulated mitochondrial quality control, including VDAC1-related mechanisms and impaired PINK1/Parkin-mediated mitophagy, further links autophagy dysfunction to neuronal injury [60,61].”
Zhao, L., Zhang, Z., Wang, P., Zhang, N., shen, H., Wu, H., Wei, Z., Yang, F., Wang, Y., Yu, Z., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03135-2 · Cited by 21 · cited 1×
“Mechanistic studies indicate the microbiota-gut–brain axis drives functional imbalance by inducing pathological overexpression of AQP4 in astrocytes [111,112].”
Cui, Y., Meng, S., Zhang, N., Liu, J., Zheng, L., Ma, W., Song, Y., Wang, Z., Shen, Y., Liu, J., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70021 · Cited by 20 · cited 1×
“Additionally, targeting the TLR4/NF-κ B axis with gugguls-terone (preclinical research) and selective mitochondrial antioxidant protection via high-concentration hydrogen inhalation are promising approaches [13,14].”
Rocha, M., Vieira, A., Michels, M., Borges, H., Goulart, A., Fernandes, F., Dominguini, D., Ritter, C., & Dal-Pizzol, F. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104906 · Cited by 20 · cited 1×
“During sepsis, these cells undergo dynamic functional transformation: early activation exerts protective effects via Foxc1-mediated I κ B α /NF-κ B signaling regulation [16]; however, sustained activation triggered by the RAGE ligand S100B exacerbates abnormal BBB permeability [17,18].”
Cui, Y., Liu, J., Song, Y., Chen, C., Shen, Y., & Xie, K. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70305 · Cited by 18
Baby, S., Reljic, T., Villalba, N., Kumar, A., & Yuan, S. Y. (2023) · PLOS ONE · doi:10.1371/journal.pone.0281941 · Cited by 17 · cited 1×
“Concurrently, the endothelial glycocalyx is sheds under inflammation and abnormal shear stress, shed components (e.g., syndecan-1) act as DAMPs to amplify inflammation, directly weakening the first physical and charge barrier against macromolecule extravasation [45,46].”
Role of Imaging Modalities and N -Acetylcysteine Treatment in Sepsis-Associated Encephalopathy
Zhong, Y., Guan, J., Ma, Y., Xu, M., Cheng, Y., Xu, L., Lin, Y., Zhang, X., & Wu, R. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00180 · Cited by 17 · cited 1×
“…drugs: N-acetylcysteine (NAC) protects the BBB through dual mechanisms of regulating glutamate metabolism and exerting antioxidant effects [101]; oxytocin improves cognition by reconstructing excitatory/inhibitory synaptic balance [102]; fluoxetine alleviates prefrontal dysfunction by…”
Yang, Y., Ke, J., Cao, Y., Gao, Y., & Lin, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117092 · Cited by 17 · cited 1×
“Intervention strategies classified by clinical transformation stage: 1 ⃝ Clinically available drugs: Melatonin induces M2 microglial polarization through AMPK α 2 activation [67].”
You, L., & Jiang, H. (2021) · Bioengineered · doi:10.1080/21655979.2021.1987066 · Cited by 17 · cited 1×
“Intervention strategies targeting BBB remodeling include: strengthening tight junctions—dihydroartemisinin (DHA) stabilizes TJ protein expression by inhibiting SNAI1 [51]; mirtazapine and cabergoline also show barrier-fortifying effects [52,53].”
Effects of MFHAS1 on cognitive impairment and dendritic pathology in the hippocampus of septic rats
Zhong, J., Guo, C., Hou, W., Shen, N., & Miao, C. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116822 · Cited by 15 · cited 1×
“In epigenetic regulation, the Neat1/Hbb axis impairs dendritic spine density by down-regulating postsynaptic density protein-95 (PSD-95) expression, while MFHAS1-siRNA intervention can significantly reduce A β pathological burden and repair dendritic morphology [99,100].”
Zhang, Z., Wang, L., Li, F., Qian, X., Hong, Z., Wu, L.-C., Jiang, Y., & Hu, H. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2101038 · Cited by 14 · cited 1×
“…via the BDNF/TrkB signaling pathway [68]; umbilical cord mesenchymal stem cells mitigate inflammation and apoptosis via the PI3K/AKT pathway [69]; fisetin inhibits IL-1 β secretion via the mitophagy-NLRP3 axis [70]; NMN alleviates oxidative damage through the NAD+/SIRT1 pathway [71]; Lrg1…”
Zhang, C., Tian, F., Peng, J., Wang, X., Li, J., Zhang, L., & Tan, Z. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14655 · Cited by 14 · cited 1×
“…excitatory/inhibitory synaptic balance [102]; fluoxetine alleviates prefrontal dysfunction by restoring serotonergic (5-HT) signaling [103]; 2 ⃝ Preclinical research: Vagus nerve stimulation exerts anti-inflammatory effects by inhibiting endothelial activation cascades while…”
Li, H., Liao, H., Zhang, C., Xu, Y., Xu, X., Chen, Y., Song, S., Li, Q., Si, Y., & Bao, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1032098 · Cited by 13 · cited 1×
“Functional imaging shows abnormally increased amplitude of low-frequency fluctuation (ALFF) values in the hippocampus, and the glutamate+glutamine (Glx)/creatine (Cr) ratio positively correlates with cognitive impairment, providing objective biomarkers for clinical assessment [95].”
Zhou, Y., Yang, Y., Yi, L., Pan, M., Tang, W., & Duan, H. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s458013 · Cited by 13 · cited 1×
“Pharmacological synergy studies demonstrate that propofol combined with dexmedeto-midine achieves multi-target intervention by regulating the Fpn1 node, reducing FTH1 expression by 58% and MDA levels by 41%, while reversing iron transporter abnormalities [92].”
Fan, Z., Ma, H., Li, Y., Wu, Y., Wang, J., Xiong, L., Fang, Z., & Zhang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.884821 · Cited by 13 · cited 1×
“Blocking the MD-2-mediated apoptosis-necroptosis signaling interaction significantly improves neuronal survival [66].”
Liu, J., Lin, Y., Yang, Y., Guo, Y., Shang, Y., Zhou, B., Liu, T., Fan, J., & Wei, C. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115149 · Cited by 12 · cited 2×
“First, BBB permeability: many promising preclinical targets tend to exhibit poor CNS penetration, requiring doses that may risk peripheral toxicity [12,13,22].”
Pu, Y., Zhao, L., Xi, Y., Xia, Y., & Qian, Y. (2022) · Bioengineered · doi:10.1080/21655979.2021.2024962 · Cited by 12 · cited 1×
“Intervention strategies targeting BBB remodeling include: strengthening tight junctions—dihydroartemisinin (DHA) stabilizes TJ protein expression by inhibiting SNAI1 [51]; mirtazapine and cabergoline also show barrier-fortifying effects [52,53].”
Insight Into Regulatory T Cells in Sepsis-Associated Encephalopathy
Gao, Y.-L., Liu, Y.-C., Zhang, X., Shou, S.-T., & Chai, Y.-F. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.830784 · Cited by 11 · cited 1×
“…tissue microenvironmental balance by suppressing excessive immune responses and can migrate across the BBB into CNS. Activation of nicotinic acetylcholine receptors on their surface promotes clonal expansion within the hippocampus and modulates neuroinflammation via acetylcholine signaling [33,34].”
Wang, P., Yan, J., Shi, Q., Yang, F., Li, X., Shen, Y., Liu, H., Xie, K., & Zhao, L. (2023) · Emergency Medicine International · doi:10.1155/2023/6676033 · Cited by 11 · cited 1×
“Mechanistic studies indicate the microbiota-gut–brain axis drives functional imbalance by inducing pathological overexpression of AQP4 in astrocytes [111,112].”
Xu, K., Huang, Q., Lyu, Y., Wang, S., Lu, Y., & Qian, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117200 · Cited by 11 · cited 1×
“Phosphatidylserine (PS) significantly downregulates hippocampal pro-inflammatory gene transcription by modulating TBK1/NLRP3 signaling [110].”
(2021) · PubMed Central · Cited by 11
Zheng, X., Li, W., Xiang, Q., Wang, Y., Qu, T., Fang, W., & Yang, H. (2023) · ACS Omega · doi:10.1021/acsomega.3c06250 · Cited by 10
Liu, C., Liu, G., Zhou, F., Chen, L., Chang, B., Tang, H., & Wang, H. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217556 · Cited by 10
Liu, F., Liu, J., Xiang, H., Sun, Z., Li, Y., Li, X., Liu, Y., & Liu, J. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13683 · Cited by 9 · cited 1×
“Intervention strategies targeting BBB remodeling include: strengthening tight junctions—dihydroartemisinin (DHA) stabilizes TJ protein expression by inhibiting SNAI1 [51]; mirtazapine and cabergoline also show barrier-fortifying effects [52,53].”
Yin, Y., Lv, G., Zhang, W., Yuan, J., Yang, Y., Wang, Y., Liu, S., Wang, S., Yan, B., Bo, H., et al. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114326 · Cited by 9 · cited 1×
“2 ⃝ Natural Compounds: β -patchoulene, β -elemene, and resveratrol glycoside exert anti-inflammatory effects by modulating pathways such as Sirt1/Nrf2 and RAC1/MLK3/p38 [30–32].”
The brain washing system in sepsis-associated encephalopathy
Chen, T., Hu, J., Liao, Y., Xie, S., & Zhang, L. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03602-4 · Cited by 8 · cited 1×
“This in turn activates calcium-dependent proteases to cleave TJ proteins and induces endothelial cell apoptosis, driving the progression of the BBB from functional leakage to structural damage [49].”
Qiu, F., Liu, Y., Liu, Y., Zhao, Z., Zhou, L., Chen, P., Du, Y., Wang, Y., Sun, H., Zeng, C., et al. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08764-z · Cited by 8 · cited 1×
“…microglia are classified by clinical transformation stage: 1 ⃝ Preclinical research: CD137L neutralizing antibody TKS-1 inhibits M1 polarization [21]; α 7nAChR agonist remimazolam activates the Nrf2/HO-1 pathway [22]; miR-25-3p inhibits IL-1 β signaling via the TLR4/NLRP3 axis [23]; miR-494…”
Yu, S.-Y. (2022) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2022.072 · Cited by 8 · cited 1×
“Multifunctional drugs such as rosuvastatin, memantine, and metformin protect endothelial cells and maintain BBB integrity through anti-inflammatory, antioxidant, and anti-excitotoxic pathways [54–56].”
He, C., Aziguli, A., Zhen, J., Jiao, A., Liao, H., Du, C., Liu, W., Aihemaitijiang, K., & Xu, A. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-1732 · Cited by 7 · cited 1×
“…stage: 1 ⃝ Preclinical research: CD137L neutralizing antibody TKS-1 inhibits M1 polarization [21]; α 7nAChR agonist remimazolam activates the Nrf2/HO-1 pathway [22]; miR-25-3p inhibits IL-1 β signaling via the TLR4/NLRP3 axis [23]; miR-494 maintains mitochondrial metabolic homeostasis [24].”
Moriyama, N., Saito, M., Ono, Y., Yamashita, K., Aoi, T., & Kotani, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134309 · Cited by 7 · cited 1×
“The γδ T cell subset exacerbates microglial activation via IL-17A signaling, and intervention with anti-γδ TCR/anti-IL-17A significantly ameliorates anxiety-like behavior [39].”
Su, W., Xie, Z., Bai, X., Li, Z., & Liu, X. (2023) · Brain Sciences · doi:10.3390/brainsci13030478 · Cited by 7 · cited 4×
“Genetic knockout experiments demonstrate that GSDMD deficiency simultaneously inhibits pyrop-tosis and autophagy [58], while dynamin-related protein 1 (DRP1) inhibitors significantly improve pathological phenotypes by reversing mitochondrial dysfunction [59] (Figure 3).”
InfluentialSelf-citationZhang, Z., Qiu, X., Zeng, X., Liu, X., Lu, J., Xu, C., Huang, J., Zhao, C., & Zhan, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-18650-2 · Cited by 6
Li, H., Liao, H., Sun, L., Chen, D., Fei, Y., Yao, M., Huang, B., Guo, X., Song, S., & Bao, H. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2307140 · Cited by 6 · cited 1×
“HMGB1 inhibitors restore synaptic pruning balance [25,26]; MFGE8 enhances α V β integrin-mediated efferocytosis [27,28]; the microglial depletion agent PLX5622 prevents synaptic engulfment [29].”
Liu, Y., Guo, L., Zhang, G., Sun, W., Yang, X., & Liu, Y. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.10822 · Cited by 5 · cited 1×
“Mitochondrial regulatory networks indicate that Nogo-A induces mitophagy and apoptosis via the ROS-p-SHP2 axis [64], while Omi/HtrA2 promotes apoptosis through dual mechanisms: inhibiting XIAP and inducing mitochondrial membrane potential depolarization [65].”
Tang, Y.-F., Duan, Y.-J., Ge, R.-D., Lu, X., Gao, B.-Y., Guo, J.-W., & Jiang, S. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2201005 · Cited by 5
(2020) · PubMed Central · doi:10.12122/j.issn.1673-4254.2020.05.06 · Cited by 4
He, T. T., Jiao, T. Q., & An, X. M. (2026) · PeerJ · doi:10.7717/peerj.20770 · Cited by 2 · cited 3×
“Most models use young, healthy mice, whereas human sepsis predominantly affects elderly patients with comorbidities that alter immune responses and BBB vulnerability [1,2].”
Platanaki, C., Paraskevas, T., Delastic, A.-L., Michailides, C., Kantanis, A., Polychronopoulos, P., Marangos, M., & Velissaris, D. (2023) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2023-0005 · Cited by 2
Li, R., Zeng, Q., Ji, M., Zhang, Y., Mao, M., Feng, S., Duan, M., & Zhou, Z. (2025) · Journal of Biomedical Research · doi:10.7555/jbr.37.20230318 · Cited by 1 · cited 1×
“…glutamate metabolism and exerting antioxidant effects [101]; oxytocin improves cognition by reconstructing excitatory/inhibitory synaptic balance [102]; fluoxetine alleviates prefrontal dysfunction by restoring serotonergic (5-HT) signaling [103]; 2 ⃝ Preclinical research: Vagus nerve…”
Cholinergic anti-inflammatory pathway plays negative regulatory role in early inflammatory and immune responses in septic rats
Li (2020) · Nan Fang Yi Ke Da Xue Xue Bao = J. South. Med. Univ.
UnresolvedThe role of cerebrospinal fluid levels of neutrophil gelatinase-associated lipocalin (NGAL) and electroencephalography in the assessment of impaired consciousness in the context of infection
Platanaki (2023) · Rom. J. Intern. Med.
UnresolvedMetformin Attenuates Brain Injury by Inhibiting Inflammation and Regulating Tight Junction Proteins in Septic Rats
Didari (2020) · Cell J.
UnresolvedKnockdown of VDAC1 alleviates the cognitive dysfunction secondary to sepsis-associated encephalopathy
Cai (2021) · Am. J. Transl. Res.
Unresolved
Metadata
- Authors
- Tan, H., Su, W., & Niu, Z.
- Affiliations
- Sichuan University (CN)
- Corresponding author
- Niu, Zhendong
- ORCID
- Tan, Haowen
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2026-06-15
- Volume
- 27
- Issue
- 12
- Pages
- 5390
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC13300322
- OpenAlex
- W7164863602
- Cited by
- 1
- References
- 116
- Citations by year
- 2026: 1
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People’s Republic of China (STI2030-Major Projects2021ZD0201900)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- sepsis-associated encephalopathy, neuroinflammation, pathogen-associated molecular patterns, damage-associated molecular patterns, microglia, regulatory T cells, neutrophils, blood-brain barrier disruption, tight junctions, programmed cell death, autophagy, apoptosis, pyroptosis, ferroptosis, mitochondrial dysfunction, glutamate excitotoxicity, cholinergic deficit, gut-brain axis, gut microbiota metabolites, butyrate, indolepropionic acid, microcirculatory disturbances
- MeSH terms
- Neuroinflammatory Diseases, Animals, Blood-Brain Barrier, Humans, Mitochondria, Sepsis, Sepsis-Associated Encephalopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.